Search results for " effect"

showing 10 items of 7524 documents

Phase IA/II Study of Oral LBH589, a Novel Deacetylase Inhibitor (DACi), Administered on 2 Schedules, in Patients with Advanced Hematologic Malignanci…

2007

Abstract LBH589 is a novel cinnamic acid hydroxamate DACi which induces apoptosis in multiple hematologic tumor cell lines in vitro at nanomolar levels. LBH589 has been administered orally, once-a-day, on Monday/Wednesday/Friday, every week (Arm 1) or every other week (Arm 2), in cycles of 28 days, to adult pts with advanced hematologic malignancies. A 3-parameter Bayesian logistic regression model guided dose escalation. To date, 61 pts, median age 67 yrs (range 16–87), 40 male, 21 female, have been enrolled: 33 pts in Arm 1 at dose levels (mg/dose) of 20 (9 pts), 30 (12 pts), 40 (10 pts), and 60 (2 pts); 28 pts in Arm 2 at dose levels (mg/dose) of 30 (7 pts), 45 (12 pts), and 60 (9 pts). …

medicine.medical_specialtybusiness.industryNauseaImmunologyPeripheral edemaCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistryGastroenterologySurgeryEvery other weekInternal medicineVomitingmedicineIn patientmedicine.symptombusinessAdverse effectFebrile neutropeniaBlood
researchProduct

Dopplersonographische Blutflußmessung der A. umbilicalis: Ist ein Screening sinnvoll?

1989

medicine.medical_specialtybusiness.industryObstetrics and GynecologyUmbilical arteryGeneral MedicineBlood flowsymbols.namesakeInternal medicinemedicine.arterysymbolsCardiologyMedicinebusinessDoppler effectArchives of Gynecology and Obstetrics
researchProduct

Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus

2010

Background  One of the major goals of pemphigus therapy is to reduce the patient’s cumulative exposure to systemic corticosteroids. To investigate the efficacy of enteric-coated mycophenolate sodium (EC-MPS), 10 patients with active, refractory pemphigus vulgaris (PV) or foliaceous (PF) were treated with EC-MPS (1440 mg daily) and prednisone (75 mg daily) over 18 months. Observations  Following EC-MPS/prednisone therapy, disease progression was inhibited between days 30 and 45 in 9/10 patients (8 PV; 1 PF). At 18 months, 8/9 PV patients had clinically quiescent disease; EC-MPS therapy was no longer required in two patients as a result of disease remission. The remaining PV patient showed no…

medicine.medical_specialtybusiness.industryPemphigus vulgarisMycophenolate SodiumAzathioprineDermatologymedicine.diseaseGastroenterologySurgeryPemphigusRefractoryPrednisoneInternal medicinemedicineAdjuvant therapyAdverse effectbusinessmedicine.drugInternational Journal of Dermatology
researchProduct

Effect of storage time and donor sex of transfused red blood cells on 1-year survival in patients undergoing cardiac surgery: an observational study

2016

BACKGROUND Red blood cell (RBC) storage lesions and RBCs from females transfused into male recipients may have adverse effects on transfusion recipients' survival. We hypothesized that the effect of donor sex and the effect of age of blood on mortality would be most apparent in cardiac surgery patients. STUDY DESIGN AND METHODS Using data from French Blood Services and two university hospitals, we conducted a retrospective cohort study on cardiac surgery patients whose first transfusion occurred between 2007 and 2011. The age of blood and donor sex effects on 1-year survival were studied using Cox regression modeling, with time-dependent stratification on the number of RBCs and adjustments …

medicine.medical_specialtybusiness.industryProportional hazards modelImmunologyHazard ratioRetrospective cohort studyHematology030204 cardiovascular system & hematologyConfidence interval3. Good healthCardiac surgerySurgery03 medical and health sciencesRed blood cell0302 clinical medicinemedicine.anatomical_structureInternal medicineImmunology and AllergyMedicine030212 general & internal medicinebusinessAdverse effectSurvival analysisTransfusion
researchProduct

Role of the hospital pharmacist in an Italian antimicrobial stewardship programme

2020

The inappropriate use of antimicrobial agents is contributing to an increasing phenomenon of bacterial resistance. For this reason, there is a growing interest in ‘antimicrobial stewardship’, a series of coordinated and multidisciplinary interventions aimed to promote the safe and appropriate use of antimicrobials in which the pharmacist’s contribution is necessary for the optimal choice of drug, dose, duration of therapy and the implementation of cost containment strategies. AIM OF THE STUDY: We wanted to create a reference model and a specific training manual on antibiotic stewardship to introduce the role of the department pharmacist with specific infection disease skills in the Italian …

medicine.medical_specialtybusiness.industryPsychological interventionPharmacistTraining manualPharmacistsCommunicable Diseases030226 pharmacology & pharmacyHospitalsClinical pharmacyAntimicrobial Stewardship03 medical and health sciences0302 clinical medicineAnti-Infective AgentsFamily medicinemedicineHumansInfection controlAntimicrobial stewardship030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsHospital pharmacybusinessAdverse effectOriginal ResearchEuropean Journal of Hospital Pharmacy
researchProduct

Occupational exposure to pesticides and congenital malformations: A review of mechanisms, methods, and results

1998

Pesticides are chemicals that are widely used all over the world. Human beings can be exposed through environmental contamination and/or occupational use of pesticides. Although there is substantial information on the acute toxicity of many of these chemicals, available knowledge on delayed effects is much more limited. This paper reviews epidemiological studies on occupational exposure to pesticides, mainly in agricultural workers, and risk of congenital malformations. The discussion includes postulated mechanisms for birth defects from paternal or maternal exposure, a detailed review of method of the studies carried out so far on the relationship between occupational exposure to pesticide…

medicine.medical_specialtybusiness.industryPublic Health Environmental and Occupational HealthCongenital malformationsEnvironmental exposurePesticideTeratologyToxicologyOccupational medicinePaternal ExposurePrenatal Exposure Delayed EffectsEnvironmental healthMedicineOccupational exposurebusinessAmerican Journal of Industrial Medicine
researchProduct

The relevance for Public Health of the mid-term and interim analyses of seasonal influenza vaccination effectiveness

2019

Worldwide, influenza is commonly recognized as a respiratory virus that causes a high number of deaths every year, especially among elderly adults and people with chronic illnesses. In order to reduce morbidity and mortality, many countries have implemented, in the last decades, universal influenza vaccination programs with special attention on groups at increased risk of developing the disease, such as pregnant women, children aged 6–59 months, elderly adults and individuals with specific chronic medical conditions. In real-world conditions, observational (nonrandomized) studies on vaccine effectiveness (VE) could measure,the risk reduction of contracting a disease and are considered the g…

medicine.medical_specialtybusiness.industryPublic healthsurveillance networktest-negative designinfluenza vaccine effectiveneSettore MED/42 - Igiene Generale E ApplicataTerm (time)VaccinationSeasonal influenzaVirologyEnvironmental healthInterimmedicineinfluenza viruseRelevance (information retrieval)influenza epidemicbusinesslaboratory confirmed case
researchProduct

Tu1253 How Safe Is Sedation in Gastrointestinal Endoscopy? a Prospective Multicenter Trial: an Interim Analysis of 73,941 Endoscopies. Data From Pros…

2013

were those plausibly associated with the procedure and severe enough for the patient to seek medical attention. We compared the proportion of patients with adverse events associated with gastrointestinal endoscopy identified with direct patient contact to the proportion identified through our current infrastructure using the chi-square statistic. Results: During the study period, 11,710 endoscopic procedures were performed on 9,683 patients. Our study personnel made 3205 calls over a three month period and ultimately made contact with 1999 (17%; 84.5% of those called) patients. 28 (1.4%) adverse events were identified through direct patient contact. Our adverse event tracking infrastructure…

medicine.medical_specialtybusiness.industrySedationGastroenterologyPatient contactInterim analysisMulticenter trialEmergency medicinemedicineRadiology Nuclear Medicine and imagingmedicine.symptomAdverse effectbusinessGastrointestinal endoscopyMedical attentionGastrointestinal Endoscopy
researchProduct

Hyaluronic Acid in the Treatment of Pain Due to Knee Joint Immobilisation

1995

This open, randomised study was carried out in order to evaluate the safety and efficacy of a course of 5 intra-articular injections (one per week) of hyaluronic acid (HA), administered to patients with pain and joint stiffness resulting from immobilisation of the knee in a plaster cast. The study was made in comparison with an untreated control group. 30 patients of both genders, aged between 18 and 65 years, immobilised in a plaster cast for at least 20 days and presenting with pain and reduced mobility, were included in the study. The results of the study show that, in comparison with the control group, treatment with HA produced a more rapid and effective reduction in pain and increase …

medicine.medical_specialtybusiness.industrySignificant differenceReduced mobilityGeneral MedicineKnee JointSurgerychemistry.chemical_compoundchemistryJoint mobilityUntreated controlJoint stiffnessHyaluronic acidmedicinePharmacology (medical)medicine.symptomAdverse effectbusinessClinical Drug Investigation
researchProduct

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

2013

Aims Mirabegron, the first β3-adrenoceptor agonist to enter clinical practice, has a different mechanism of action from antimuscarinic agents. This review presents data on the efficacy, safety, and tolerability of mirabegron in studies conducted to date. Methods All clinical data on mirabegron that are currently in the public domain are included, including some in-press manuscripts. Results In Phase III clinical trials in patients with overactive bladder (OAB), mirabegron at daily doses of 25, 50, and 100 mg demonstrated significant efficacy in treating the symptoms of OAB, including micturition frequency, urgency incontinence, and urgency. Significant improvements in micturition frequency,…

medicine.medical_specialtybusiness.industryUrologyPlacebomedicine.diseaseSurgeryDiscontinuationClinical trialOveractive bladderTolerabilityInternal medicinemedicineNeurology (clinical)TolterodineMirabegronbusinessAdverse effectmedicine.drugNeurourology and Urodynamics
researchProduct